Published in Int Wound J on October 01, 2008
Inflammation and wound healing: the role of the macrophage. Expert Rev Mol Med (2011) 2.13
Abnormal cell responses and role of TNF-α in impaired diabetic wound healing. Biomed Res Int (2013) 1.02
Tumor necrosis factor-alpha induced expression of matrix metalloproteinase-9 through p21-activated kinase-1. BMC Immunol (2009) 1.02
Translational lessons from scarless healing of cutaneous wounds and regenerative repair of the myocardium. J Mol Cell Cardiol (2009) 0.99
Cardiac to cancer: connecting connexins to clinical opportunity. FEBS Lett (2014) 0.96
Predicting development of proliferative diabetic retinopathy. Diabetes Care (2012) 0.95
Glucose toxic effects on granulation tissue productive cells: the diabetics' impaired healing. Biomed Res Int (2012) 0.87
The Role of MicroRNAs in Diabetic Complications-Special Emphasis on Wound Healing. Genes (Basel) (2014) 0.86
Ganglioside GM3 depletion reverses impaired wound healing in diabetic mice by activating IGF-1 and insulin receptors. J Invest Dermatol (2013) 0.84
Amelioration in wound healing in diabetic toll-like receptor-4 knockout mice. J Diabetes Complications (2013) 0.84
Topical administration of a connexin43-based peptide augments healing of chronic neuropathic diabetic foot ulcers: A multicenter, randomized trial. Wound Repair Regen (2015) 0.83
Toll-like receptor expression and signaling in human diabetic wounds. World J Diabetes (2014) 0.82
Oral Administration of Linoleic Acid Induces New Vessel Formation and Improves Skin Wound Healing in Diabetic Rats. PLoS One (2016) 0.80
Age-related macular degeneration: beyond anti-angiogenesis. Mol Vis (2014) 0.79
Compromised Wound Healing in Ischemic Type 2 Diabetic Rats. PLoS One (2016) 0.76
Superficial wound swabbing: a novel method of sampling and processing wound fluid for subsequent immunoassay analysis in diabetic foot ulcerations. Diabetes Care (2012) 0.76
Impaired T-cell differentiation in diabetic foot ulceration. Cell Mol Immunol (2016) 0.75
Low-level laser irradiation effect on endothelial cells under conditions of hyperglycemia. Lasers Med Sci (2016) 0.75
Keratinocyte nicotinic acetylcholine receptor activation modulates early TLR2-mediated wound healing responses. Int Immunopharmacol (2015) 0.75
Toll-like receptors-2 and -9 (TLR2 and TLR9) gene polymorphism in patients with type 2 diabetes and diabetic foot. Medicine (Baltimore) (2017) 0.75
Diabetes mellitus affects the biomechanical function of the callus and the expression of TGF-beta1 and BMP2 in an early stage of fracture healing. Braz J Med Biol Res (2015) 0.75
From Inflammation to Current and Alternative Therapies Involved in Wound Healing. Int J Inflam (2017) 0.75
Microbiota of Chronic Diabetic Wounds: Ecology, Impact, and Potential for Innovative Treatment Strategies. Front Microbiol (2017) 0.75
Future research directions in idiopathic pulmonary fibrosis: summary of a National Heart, Lung, and Blood Institute working group. Am J Respir Crit Care Med (2002) 1.76
Interference with transforming growth factor-beta/ Smad3 signaling results in accelerated healing of wounds in previously irradiated skin. Am J Pathol (2003) 1.64
Preparing the wound bed 2003: focus on infection and inflammation. Ostomy Wound Manage (2003) 1.63
Ratios of activated matrix metalloproteinase-9 to tissue inhibitor of matrix metalloproteinase-1 in wound fluids are inversely correlated with healing of pressure ulcers. Wound Repair Regen (2002) 1.51
Connective tissue growth factor expression and action in human corneal fibroblast cultures and rat corneas after photorefractive keratectomy. Invest Ophthalmol Vis Sci (2003) 1.31
Involvement of CTGF in TGF-beta1-stimulation of myofibroblast differentiation and collagen matrix contraction in the presence of mechanical stress. Invest Ophthalmol Vis Sci (2004) 1.26
Matrix metalloproteinase inhibition modulates fibroblast-mediated matrix contraction and collagen production in vitro. Invest Ophthalmol Vis Sci (2003) 1.20
TGF-beta- and CTGF-mediated fibroblast recruitment influences early outward vein graft remodeling. Am J Physiol Heart Circ Physiol (2007) 1.16
Methylglyoxal administration induces diabetes-like microvascular changes and perturbs the healing process of cutaneous wounds. Clin Sci (Lond) (2005) 1.13
Expression of connective tissue growth factor after glaucoma filtration surgery in a rabbit model. Invest Ophthalmol Vis Sci (2004) 1.12
Mediation of transforming growth factor-beta(1)-stimulated matrix contraction by fibroblasts: a role for connective tissue growth factor in contractile scarring. Am J Pathol (2003) 1.11
Immunohistochemical localization of EGF, TGF-alpha, TGF-beta, and their receptors in rat corneas during healing of excimer laser ablation. Curr Eye Res (2006) 1.07
Gene transfer into rabbit keratocytes using AAV and lipid-mediated plasmid DNA vectors with a lamellar flap for stromal access. Exp Eye Res (2003) 1.07
Simvastatin inhibits growth factor expression and modulates profibrogenic markers in lung fibroblasts. Am J Respir Cell Mol Biol (2005) 1.03
Early differential MMP-2 and -9 dynamics during flow-induced arterial and vein graft adaptations. J Surg Res (2006) 0.97
TGFbeta stimulated re-epithelialisation is regulated by CTGF and Ras/MEK/ERK signalling. Exp Cell Res (2007) 0.96
Prophylactic use of epidermal growth factor reduces ischemia/reperfusion intestinal damage. Am J Pathol (2002) 0.96
Temporal patterns of gene expression in murine cutaneous burn wound healing. Physiol Genomics (2004) 0.95
Differential expression and activity of matrix metalloproteinases during flow-modulated vein graft remodeling. J Vasc Surg (2004) 0.95
CCN2/CTGF regulates neovessel formation via targeting structurally conserved cystine knot motifs in multiple angiogenic regulators. FASEB J (2012) 0.94
Topical advances in wound care. Gynecol Oncol (2008) 0.93
A connective tissue growth factor signaling receptor in corneal fibroblasts. Invest Ophthalmol Vis Sci (2012) 0.92
Development of a microarray chip for gene expression in rabbit ocular research. Mol Vis (2007) 0.92
Microarray analysis of gene expression patterns during healing of rat corneas after excimer laser photorefractive keratectomy. Invest Ophthalmol Vis Sci (2002) 0.92
Growth factor, cytokine and protease interactions during corneal wound healing. Ocul Surf (2003) 0.91
Microarray analysis of the failure of filtering blebs in a rat model of glaucoma filtering surgery. Invest Ophthalmol Vis Sci (2004) 0.90
Targeted decorin gene therapy delivered with adeno-associated virus effectively retards corneal neovascularization in vivo. PLoS One (2011) 0.90
Detection of connective tissue growth factor (CTGF) in human tear fluid: preliminary results. Acta Ophthalmol Scand (2003) 0.90
Hammerhead ribozyme targeting connective tissue growth factor mRNA blocks transforming growth factor-beta mediated cell proliferation. Exp Eye Res (2004) 0.89
Immunogenicity of 10 and 20 microgram hepatitis B vaccine in a two-dose schedule. Vaccine (2003) 0.89
Role of connective tissue growth factor in breast implant elastomer capsular formation. Ann Plast Surg (2003) 0.88
Vorinostat: a potent agent to prevent and treat laser-induced corneal haze. J Refract Surg (2012) 0.88
MicroRNA signature in wound healing following excimer laser ablation: role of miR-133b on TGFβ1, CTGF, SMA, and COL1A1 expression levels in rabbit corneal fibroblasts. Invest Ophthalmol Vis Sci (2013) 0.88
Glucose toxic effects on granulation tissue productive cells: the diabetics' impaired healing. Biomed Res Int (2012) 0.87
Proteolytic processing of connective tissue growth factor in normal ocular tissues and during corneal wound healing. Invest Ophthalmol Vis Sci (2012) 0.86
Development of a novel ex vivo porcine skin explant model for the assessment of mature bacterial biofilms. Wound Repair Regen (2013) 0.86
Connective tissue growth factor and integrin αvβ6: a new pair of regulators critical for ductular reaction and biliary fibrosis in mice. Hepatology (2015) 0.86
Science and strategy for preventing and managing corneal ulceration. Ocul Surf (2007) 0.85
Conditional knockout of CTGF affects corneal wound healing. Invest Ophthalmol Vis Sci (2014) 0.85
Time course of lesion development in the hairless guinea-pig model of sulfur mustard-induced dermal injury. Wound Repair Regen (2011) 0.85
The effect of topical tripeptide-copper complex on healing of ischemic open wounds. Vet Surg (2003) 0.85
Epidermal growth factor intralesional infiltrations can prevent amputation in patients with advanced diabetic foot wounds. Int Wound J (2006) 0.85
Detection of connective tissue growth factor in human aqueous humor. Ophthalmic Res (2002) 0.85
Intra-lesional injections of recombinant human epidermal growth factor promote granulation and healing in advanced diabetic foot ulcers: multicenter, randomised, placebo-controlled, double-blind study. Int Wound J (2009) 0.85
Effect of Vacuum-Assisted Closure Therapy on the expression of cytokines and proteases in wound fluid of adults with pressure ulcers. Wound Repair Regen (2006) 0.84
Analysis of gene expression patterns in human postburn hypertrophic scars. J Burn Care Rehabil (2003) 0.84
Wound dressing components degrade proteins detrimental to wound healing. Int Wound J (2008) 0.84
Ectopic epithelial implants following surface ablation of the cornea. Invest Ophthalmol Vis Sci (2012) 0.83
Prevention of ocular scarring post glaucoma filtration surgery using the inflammatory cell and platelet binding modulator saratin in a rabbit model. PLoS One (2012) 0.83
Tympanic membrane metalloproteinase inflammatory response. Otolaryngol Head Neck Surg (2003) 0.82
Effect of connective tissue growth factor on protein kinase expression and activity in human corneal fibroblasts. Invest Ophthalmol Vis Sci (2012) 0.82
Immunogenicity of a recombinant, yeast-derived, anti-hepatitis-B vaccine after alternative dosage and schedule vaccination in Pakistani children. Vaccine (2005) 0.81
Hammerhead ribozyme-mediated knockdown of mRNA for fibrotic growth factors: transforming growth factor-beta 1 and connective tissue growth factor. Methods Mol Biol (2012) 0.81
Prevention of ocular scarring after glaucoma filtering surgery using the monoclonal antibody LT1009 (Sonepcizumab) in a rabbit model. J Glaucoma (2013) 0.81
Bioequivalence of two recombinant interferon alpha-2b liquid formulations in healthy male volunteers. Drugs R D (2004) 0.81
Safety and Immunogenicity of a Human Papillomavirus Peptide Vaccine (CIGB-228) in Women with High-Grade Cervical Intraepithelial Neoplasia: First-in-Human, Proof-of-Concept Trial. ISRN Obstet Gynecol (2011) 0.81
Reduction in severity of a herpes simplex virus type 1 murine infection by treatment with a ribozyme targeting the UL20 gene RNA. J Virol (2008) 0.81
Alpha 1-antitrypsin and ilomastat inhibit inflammatory proteases present in human middle ear effusions. Laryngoscope (2003) 0.80
Use of growth-hormone-releasing peptide-6 (GHRP-6) for the prevention of multiple organ failure. Clin Sci (Lond) (2006) 0.80
Treatment of advanced, recurrent, resistant to previous treatments basal and squamous cell skin carcinomas with a synergistic formulation of interferons. Open, prospective study. BMC Cancer (2009) 0.79
Matrix metalloproteinases in a gerbil cholesteatoma model. Otolaryngol Head Neck Surg (2003) 0.79
TIME heals all wounds. Nursing (2004) 0.79
Evaluation of various compounds to inhibit activity of matrix metalloproteinases in the tear film of horses with ulcerative keratitis. Am J Vet Res (2003) 0.78
The progression of haze formation in rabbit corneas following phototherapeutic keratectomy. Invest Ophthalmol Vis Sci (2013) 0.78
Comparison of single versus multiple injections of the protein saratin for prolonging bleb survival in a rabbit model. Invest Ophthalmol Vis Sci (2012) 0.78
A corneal scarring model. Methods Mol Biol (2013) 0.78
Alteration of Smad3 signaling in ischemic rabbit dermal ulcer wounds. Wound Repair Regen (2007) 0.78
The effect of negative pressure wound therapy with periodic instillation using antimicrobial solutions on Pseudomonas aeruginosa biofilm on porcine skin explants. Int Wound J (2013) 0.78
Methods in reepithelialization. A porcine model of partial-thickness wounds. Methods Mol Med (2003) 0.77
Arginine metabolites in wound fluids from pressure ulcers: a pilot study. Biol Res Nurs (2008) 0.76
Microbial barriers. Clin Plast Surg (2012) 0.76
Republication of color figures. Arch Ophthalmol (2002) 0.75
Alpha1-antitrypsin single dose adjuvant therapy for acute otitis media. Otolaryngol Head Neck Surg (2006) 0.75
Topical dexamethasone and tympanic membrane perforation healing in otitis media: a short-term study. Otol Neurotol (2010) 0.75
Protease inhibitors alpha1-antitrypsin and ilomastat are not ototoxic in the chinchilla. Laryngoscope (2003) 0.75
Inhibition of matrix metalloproteinases in gerbil cholesteatoma: preliminary findings. Otolaryngol Head Neck Surg (2002) 0.75
Inflammatory proteases in chronic otitis externa. Laryngoscope (2005) 0.75
Combat Wound Initiative program. Mil Med (2010) 0.75